Bristol Myers Squibb’s social media savvy nabbed it the top spot in Ogilvy Health’s newest report ranking of ten leading Big Pharmas. It was followed by Boehringer, Roche, GSK and AstraZeneca to round out the top five receiving the best overall scores.
BMS led in the specific areas of content strategy and social influence across the six social measures Ogilvy scores the pharmas on. Ogilvy evaluated the pharmas in six social measures, including corporate identity, experience and design, paid social, and social community, along with strategy and influence. Its research audited pharma engagement on social channels Facebook, Instagram, Twitter, YouTube and LinkedIn.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 161,100+ biopharma pros reading Endpoints daily — and it's free.
"cros" - Google News
February 23, 2023 at 10:47PM
https://ift.tt/ACR1ukl
Pfizer cuts CRO unicorn from Lyme vaccine trial in dispute over ... - Endpoints News
"cros" - Google News
https://ift.tt/4IwQjB9
https://ift.tt/WZHUV3B
Bagikan Berita Ini
0 Response to "Pfizer cuts CRO unicorn from Lyme vaccine trial in dispute over ... - Endpoints News"
Post a Comment